Bioage Labs, Stock Buy Hold or Sell Recommendation
| BIOA Stock | 19.70 0.63 3.30% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding BioAge Labs, is 'Strong Sell'. Macroaxis provides BioAge Labs, buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BIOA positions.
Check out BioAge Labs, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide. In addition, we conduct extensive research on individual companies such as BioAge and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards BioAge Labs,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
BioAge |
Execute BioAge Labs, Buy or Sell Advice
The BioAge recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on BioAge Labs,. Macroaxis does not own or have any residual interests in BioAge Labs, or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute BioAge Labs,'s advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
BioAge Labs, Trading Alerts and Improvement Suggestions
| BioAge Labs, had very high historical volatility over the last 90 days | |
| BioAge Labs, has high likelihood to experience some financial distress in the next 2 years | |
| BioAge Labs, has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Net Loss for the year was (63.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| BioAge Labs, currently holds about 4.63 M in cash with (37.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| Latest headline from gurufocus.com: BioAge Labs to Present at Upcoming Investor Conferences |
BioAge Labs, current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. BioAge analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. BioAge analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
BioAge Labs, Returns Distribution Density
The distribution of BioAge Labs,'s historical returns is an attempt to chart the uncertainty of BioAge Labs,'s future price movements. The chart of the probability distribution of BioAge Labs, daily returns describes the distribution of returns around its average expected value. We use BioAge Labs, price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of BioAge Labs, returns is essential to provide solid investment advice for BioAge Labs,.
| Mean Return | 0.31 | Value At Risk | -10.11 | Potential Upside | 8.26 | Standard Deviation | 5.47 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of BioAge Labs, historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
BioAge Labs, Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BioAge Labs, or Pharmaceutical Products sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BioAge Labs,'s price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BioAge stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.23 | |
β | Beta against Dow Jones | 0.60 | |
σ | Overall volatility | 5.41 | |
Ir | Information ratio | 0.03 |
BioAge Labs, Volatility Alert
BioAge Labs, exhibits above-average semi-deviation for your current time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure BioAge Labs,'s stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact BioAge Labs,'s stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.BioAge Labs, Fundamentals Vs Peers
Comparing BioAge Labs,'s fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BioAge Labs,'s direct or indirect competition across all of the common fundamentals between BioAge Labs, and the related equities. This way, we can detect undervalued stocks with similar characteristics as BioAge Labs, or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of BioAge Labs,'s fundamental indicators could also be used in its relative valuation, which is a method of valuing BioAge Labs, by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare BioAge Labs, to competition |
| Fundamentals | BioAge Labs, | Peer Average |
| Current Valuation | 539.05 M | 16.62 B |
| Shares Outstanding | 34.17 M | 571.82 M |
| Shares Owned By Insiders | 3.80 % | 10.09 % |
| Shares Owned By Institutions | 32.64 % | 39.21 % |
| Number Of Shares Shorted | 2.21 M | 4.71 M |
| Price To Earning | (0.84) X | 28.72 X |
| EBITDA | (45.81 M) | 3.9 B |
| Net Income | (63.85 M) | 570.98 M |
| Cash And Equivalents | 4.63 M | 2.7 B |
| Cash Per Share | 0.04 X | 5.01 X |
| Total Debt | 53.25 M | 5.32 B |
| Debt To Equity | 172.10 % | 48.70 % |
| Current Ratio | 1.35 X | 2.16 X |
| Book Value Per Share | (114.37) X | 1.93 K |
| Cash Flow From Operations | (37.36 M) | 971.22 M |
| Earnings Per Share | (5.40) X | 3.12 X |
| Number Of Employees | 56 | 18.84 K |
| Beta | 4.19 | -0.15 |
| Market Capitalization | 674.12 M | 19.03 B |
| Total Asset | 25.92 M | 29.47 B |
| Retained Earnings | (181.7 M) | 9.33 B |
| Working Capital | (32.86 M) | 1.48 B |
| Current Asset | 10.84 M | 9.34 B |
| Current Liabilities | 29.68 M | 7.9 B |
| Net Asset | 25.92 M |
BioAge Labs, Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as BioAge . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About BioAge Labs, Buy or Sell Advice
When is the right time to buy or sell BioAge Labs,? Buying financial instruments such as BioAge Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having BioAge Labs, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Giant Impact Thematic Idea Now
Giant Impact
An experimental equal-weighted decomposition of large high potential stocks based on Macroaxis scoring framework. The Giant Impact theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Giant Impact Theme or any other thematic opportunities.
| View All Next | Launch |
Check out BioAge Labs, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAge Labs,. If investors know BioAge will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAge Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.40) |
The market value of BioAge Labs, is measured differently than its book value, which is the value of BioAge that is recorded on the company's balance sheet. Investors also form their own opinion of BioAge Labs,'s value that differs from its market value or its book value, called intrinsic value, which is BioAge Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAge Labs,'s market value can be influenced by many factors that don't directly affect BioAge Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAge Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAge Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAge Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.